Many patients need intravenous antibiotics for serious infections. Often, they stay in hospitals for weeks receiving these powerful drugs through a vein. This approach carries risks and costs. A new trial tested a different path. It looked at patients who needed two weeks or more of IV treatment for infections outside the brain and spine. The researchers compared those who switched to oral pills early against those who stayed on IVs only. The results were clear. Patients who moved to oral medication early had significantly fewer side effects. Their risk of any bad event dropped from 6.5 percent down to 3.2 percent. This difference was real and statistically significant. The early switch did not hurt how well the drugs worked. Both groups healed just as well. The study took place across five hospitals in a rural health system. This setting matters because rural areas often face unique challenges in care delivery. The trial also found a strong link between program consultation and patient enrollment. This suggests that better coordination helps more people get into the program. The team followed patients for three months to watch for problems. No serious safety issues were reported for the group that switched early. This trial shows that changing practice can help rural patients avoid unnecessary hospital time and side effects.
Switching to oral antibiotics early cut side effects for rural patients
Photo by Raimond Klavins / Unsplash
What this means for you:
Switching to oral antibiotics early reduced side effects without losing effectiveness for rural patients.